Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.
ITARECIPE is a multicenter national registry designed to study the diagnosis and evolution of Chronic Pancreatitis
Age >/= 12 years; [+2]
Age < 12 years; [+1]
Assess the prevalence of minimally invasive pancreatic surgery in the country and its outcomes
Age > 18 years; [+1]
Pregnant woman [+1]
The goal of the PROPH-ITA Study is to perform genetic testing in family members of pancreatic cancer patients who may have a genetic predisposition. The subjects belong to the Italian Registry of Families At Risk of Pancreatic Cancer (IRFARPC, #NCT04095195). This investigational study will assess the genetic background of subjects with familiarity with pancreatic cancer only. Participants may accept to undergo genetic testing as part of the IRFARPC registry, through a saliva-swab-based 41-gene panel test. Up to 3,000 participants will be enrolled in this study.
Being enrolled on the IRFARPC registry [+2]
IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.
individuals with at least two relatives suffering from pancreatic cancer, with a... [+8]